Skip to main content
SpringerLink
Log in

Cost Considerations in the Drug Treatment of Hypertension

Is Older Better?

  • Current Opinion
  • Cost in Treating Hypertension
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Holme I, Ekelund LG, Hjermann I, et al. Quality—adjusted meta—analysis of the hypertension/coronary dilemma. Am J Hypertens 1994; 7: 703–12

    PubMed  CAS  Google Scholar 

  2. Kaplan NM. Measurement of the blood pressure. In: Kaplan NM, editor. Clinical hypertension. 6th ed. Baltimore: Williams and Wilkins, 1994: 23–45

    Google Scholar 

  3. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150: 1881–4

    Article  PubMed  CAS  Google Scholar 

  4. Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure: the fifth report of the Joint National Committee on Detection. Evaluation, and Treatmentof High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154–83

    Article  Google Scholar 

  5. Johannesson M. Economic evaluation of hypertension treatment Textbook of hypertension. Oxford: Blackwell Scientific Publications, 1994: 1292–302

    Google Scholar 

  6. Hilleman DE, Mohiuddin SM, Lucas Jr BD, et al. Cost—minimization analysis of initial anti—hypertensive therapy in patientswith mild—to—moderate essential diastolic hypertension. Clin Ther 1994: 16: 88–102

    PubMed  CAS  Google Scholar 

  7. Kaplan NM. Cost—effectiveness of anti—hypertensive drugs: fact or fancy? Am J Hypertens 1991; 4: 478–80

    PubMed  CAS  Google Scholar 

  8. Selar DA, Tessier GC, Skaer TL, et al. Effect of pharmaceutical formulation of diltiazem on the utilization of medicaid andhealth maintenance organization services. Curr Ther Res 1994; 55: 1136–49

    Article  Google Scholar 

  9. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolatedsystolic hypertension: final results of the Systolic Hypertensionin the Elderly Program (SHEP). JAMA 1991; 265: 3255–64

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas, TX 75235-8899, USA

    Norman M. Kaplan

Authors
  1. Norman M. Kaplan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaplan, N.M. Cost Considerations in the Drug Treatment of Hypertension. Pharmacoeconomics 9, 283–285 (1996). https://doi.org/10.2165/00019053-199609040-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199609040-00001

Keywords

Search

Navigation